Schrodinger Inc. (SDGR) is a leading innovator in the field of computational drug design, harnessing its sophisticated physics-based software platform to revolutionize the discovery and optimization of novel therapeutic and material compounds. Headquartered in New York, the company leverages cutting-edge computational methodologies to enhance efficiency, reduce costs, and accelerate time-to-market for pharmaceuticals. Its strategic partnerships with biotech and pharmaceutical firms position Schrodinger as an indispensable ally in overcoming the intricate challenges of drug development, making it an attractive opportunity for institutional investors seeking exposure to transformative advancements in healthcare and materials science. Show more
Location: 1540 BROADWAY, NEW YORK, NY, UNITED STATES, 10036, 24th Floor, New York, NY, 10036, USA | Website: https://www.schrodinger.com | Industry: HEALTH INFORMATION SERVICES | Sector: HEALTHCARE
Market Cap
1.029B
52 Wk Range
$13.44 - $28.47
Previous Close
$13.97
Open
$13.88
Volume
1,261,089
Day Range
$13.67 - $14.32
Enterprise Value
749.4M
Cash
181.9M
Avg Qtr Burn
-61.87M
Insider Ownership
2.58%
Institutional Own.
-
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
SGR-1505 Details Cancer, B-cell malignancies | Phase 1 Data readout | |
SGR-3515 Details Solid tumor/s | Phase 1 Data readout | |
SGR-2921 Details Myelodysplastic syndrome, Acute myeloid leukemia | Failed Discontinued |
